156 related articles for article (PubMed ID: 19056846)
1. CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.
Pallares J; Llobet D; Santacana M; Eritja N; Velasco A; Cuevas D; Lopez S; Palomar-Asenjo V; Yeramian A; Dolcet X; Matias-Guiu X
Am J Pathol; 2009 Jan; 174(1):287-96. PubMed ID: 19056846
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.
Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X
Int J Gynecol Pathol; 2005 Jul; 24(3):247-53. PubMed ID: 15968200
[TBL] [Abstract][Full Text] [Related]
3. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.
Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X
Oncogene; 2008 Apr; 27(18):2513-24. PubMed ID: 17982483
[TBL] [Abstract][Full Text] [Related]
4. FGFR2 alterations in endometrial carcinoma.
Gatius S; Velasco A; Azueta A; Santacana M; Pallares J; Valls J; Dolcet X; Prat J; Matias-Guiu X
Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis.
Haughian JM; Reno EM; Thorne AM; Bradford AP
Int J Cancer; 2009 Dec; 125(11):2556-64. PubMed ID: 19672862
[TBL] [Abstract][Full Text] [Related]
6. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.
Llobet D; Eritja N; Domingo M; Bergada L; Mirantes C; Santacana M; Pallares J; Macià A; Yeramian A; Encinas M; Moreno-Bueno G; Palacios J; Lewis RE; Matias-Guiu X; Dolcet X
Am J Pathol; 2011 Apr; 178(4):1529-43. PubMed ID: 21435442
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia.
Santacana M; Yeramian A; Velasco A; Bergada L; Gatius S; García V; Azueta A; Palacios J; Dolcet X; Oliva E; Matias-Guiu X
Histopathology; 2012 Feb; 60(3):460-71. PubMed ID: 22276609
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
Zhang XH; Hu P; Xie YQ; Kang YJ; Li M
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078
[TBL] [Abstract][Full Text] [Related]
9. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin mediates antiproliferative and apoptotic responses in endometrial carcinoma by the AdipoRs/AMPK pathway.
Zhang L; Wen K; Han X; Liu R; Qu Q
Gynecol Oncol; 2015 May; 137(2):311-20. PubMed ID: 25703675
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.
Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X
J Pathol; 2004 Dec; 204(5):569-77. PubMed ID: 15481028
[TBL] [Abstract][Full Text] [Related]
13. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
[TBL] [Abstract][Full Text] [Related]
14. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
15. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
16. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
17. Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.
Alcaraz E; Vilardell J; Borgo C; Sarró E; Plana M; Marin O; Pinna LA; Bayascas JR; Meseguer A; Salvi M; Itarte E; Ruzzene M
PLoS One; 2020; 15(1):e0227340. PubMed ID: 31910234
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
Qiao Q; Li H
Biochem Biophys Res Commun; 2016 Sep; 478(2):507-12. PubMed ID: 27381864
[TBL] [Abstract][Full Text] [Related]
19. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1, a key regulator of cell viability in endometrial cancer.
Choi DS; Kim JH; Ryu HS; Kim HC; Han JH; Lee JS; Min CK
Int J Cancer; 2007 Aug; 121(4):741-50. PubMed ID: 17455248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
